Home › Funds › BECK MACK & OLIVER LLC › LH

BECK MACK & OLIVER LLC position in LH

LABCORP HOLDINGS INC · Health Care

BECK MACK & OLIVER LLC reported holding 605,243 shares of LH (LABCORP HOLDINGS INC) in its Q2 2026 13F filing — a position valued at US$169.5M, representing 3.57% of its reported portfolio and ranking #12 among its reported holdings. BECK MACK & OLIVER LLC has disclosed LH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)605.24K sh
Reported value held$169.47M
Portfolio Weight3.57%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BECK MACK & OLIVER LLC's LH position evolved

BECK MACK & OLIVER LLC first disclosed a stake in LH in Q3 2023 at 556,273 shares (US$111.8M). The position peaked in Q3 2025 at 610,845 shares, worth US$175.3M. Across 12 filings, BECK MACK & OLIVER LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 605,243 shares valued at US$169.5M — a reduction of -11,388 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 556.27K $111.84M New
Q4 2023 549.25K $124.84M Reduce
Q1 2024 594.60K $129.90M Add
Q2 2024 600.02K $122.11M Add
Q3 2024 605.79K $135.38M Add
Q4 2024 613.03K $140.58M Add
Q1 2025 627.02K $145.93M Add
Q2 2025 614.03K $161.19M Reduce
Q3 2025 610.85K $175.35M Reduce
Q4 2025 627.04K $157.31M Add
Q1 2026 616.63K $164.52M Reduce
Q2 2026 605.24K $169.47M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 30 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.35B), Boston Partners (US$854.2M), Allspring Global Investments Holdings, LLC (US$635.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has BECK MACK & OLIVER LLC held LH?

BECK MACK & OLIVER LLC has disclosed LH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BECK MACK & OLIVER LLC's current position in LH?

As of Q2 2026, BECK MACK & OLIVER LLC holds 605.24K shares of LH (LABCORP HOLDINGS INC), valued at $169.47M, representing 3.57% of its reported portfolio and ranking #12.

Has BECK MACK & OLIVER LLC been buying or selling LH?

In the latest 13F filing (Q2 2026), BECK MACK & OLIVER LLC reduced its position in LH. The position peaked in Q3 2025 at 610.85K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.